AbCellera Biologics (ABCL) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Peter Thiel has announced his retirement from the Board of Directors of AbCellera Biologics Inc., effective March 7, 2024, for personal reasons. His departure is amicable, with no disagreements reported regarding the company’s operations. Following his exit, Dr. Andrew Lo will join the Nominating and Corporate Governance Committee, and the board will downsize from six to five members. The company has publicly released this information in a recent press statement.
For further insights into ABCL stock, check out TipRanks’ Stock Analysis page.